 Connection
Dylann Fujimoto to Humans
This is a "connection" page, showing publications Dylann Fujimoto has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.076 |
|
|
|
-
Fujimoto DK, von Eyben R, Usoz M, Kidd EA. Improving brachytherapy efficiency with dedicated dosimetrist planners. Brachytherapy. 2019 Jan - Feb; 18(1):103-107.
Score: 0.014
-
Fujimoto D, von Eyben R, Gibbs IC, Chang SD, Li G, Harsh GR, Hancock S, Fischbein N, Soltys SG. Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur. J Neurooncol. 2018 Jan; 136(1):207-212.
Score: 0.013
-
Mendoza MG, Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Adler JR, Harraher C, Li G, Gephart MH, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG. Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide. Pract Radiat Oncol. 2023 May-Jun; 13(3):e239-e245.
Score: 0.005
-
Harris JP, Fujimoto DK, Nagasaka M, Ku E, Harada G, Keshava H, Mahtabifard A, Longoria J, Patel N, Seyedin S, Simon A, Chen A. Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations. Clin Lung Cancer. 2022 06; 23(4):333-344.
Score: 0.004
-
Rahimy E, Dudley SA, von Eyben R, Pollom EL, Seiger K, Modlin L, Wynne J, Fujimoto D, Jacobs LR, Chang SD, Gibbs IC, Hancock SL, Adler JR, Li G, Choi CYH, Soltys SG. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes. Am J Clin Oncol. 2021 11 01; 44(11):588-595.
Score: 0.004
-
Houshyar R, Glavis-Bloom J, Bui TL, Chahine C, Bardis MD, Ushinsky A, Liu H, Bhatter P, Lebby E, Fujimoto D, Grant W, Tran-Harding K, Landman J, Chow DS, Chang PD. Outcomes of Artificial Intelligence Volumetric Assessment of Kidneys and Renal Tumors for Preoperative Assessment of Nephron-Sparing Interventions. J Endourol. 2021 09; 35(9):1411-1418.
Score: 0.004
-
Kozak MM, Usoz M, Fujimoto D, von Eyben R, Kidd E. Prospective randomized trial of email and/or telephone reminders to enhance vaginal dilator compliance in patients undergoing brachytherapy for gynecologic malignancies. Brachytherapy. 2021 Jul-Aug; 20(4):788-795.
Score: 0.004
-
Rahimy E, Usoz M, von Eyben R, Fujimoto D, Watanabe D, Karam A, Jairam-Thodla A, Mills M, Dorigo O, Diver EJ, Teng N, English D, Kidd E. Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors. Gynecol Oncol. 2021 04; 161(1):275-281.
Score: 0.004
-
Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, Kidd E. Recurrence risk factors in stage IA grade 1 endometrial cancer. J Gynecol Oncol. 2021 03; 32(2):e22.
Score: 0.004
-
Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Harsh GR, Adler JR, Harraher C, Li G, Hayden Gephart M, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG. A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Neuro Oncol. 2020 08 17; 22(8):1182-1189.
Score: 0.004
-
Usoz M, von Eyben R, Fujimoto DK, Kidd EA. Improving gynecologic brachytherapy patient experience by optimizing MRI, anesthesia, and scheduling to decrease the length of time tandem and ovoid applicators are in place. Brachytherapy. 2020 Mar - Apr; 19(2):162-167.
Score: 0.004
-
Chin AL, Fujimoto D, Kumar KA, Tupper L, Mansour S, Chang SD, Adler JR, Gibbs IC, Hancock SL, Dodd R, Li G, Gephart MH, Ratliff JK, Tse V, Usoz M, Sachdev S, Soltys SG. Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. Neurosurgery. 2019 11 01; 85(5):708-716.
Score: 0.004
-
Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG. Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res. 2018 Mar 01; 59(suppl_1):i11-i18.
Score: 0.003
-
Pollom EL, Fujimoto D, Wynne J, Seiger K, Modlin LA, Jacobs LR, Azoulay M, von Eyben R, Tupper L, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR, Harsh GR, Harraher C, Nagpal S, Thomas RP, Recht LD, Choi CYH, Soltys SG. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):123-130.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|